Louise

What Louise does

Louise (legally Sofia SAS, headquartered at 406 BD Jean Jacques Bosc, 33130 Bègles, France) is a private company building an AI-powered reproductive intelligence platform that addresses the full reproductive health journey. The company operates a multi-sided platform spanning six customer segments: patients (direct-to-consumer), fertility clinics and healthcare providers, health systems, payers and insurance companies, employers offering fertility benefits, and life sciences companies. Its core technology is described as the only AI infrastructure built exclusively for human reproduction, featuring end-to-end clinical reasoning that synthesizes complete reproductive timelines, delivers individualized clinical reasoning at the point of care, applies predictive models for OHSS risk, gonadotropin dosing, embryo-level outcomes, and endometrial receptivity, monitors dynamic risk signals across the cycle, continuously synthesizes the latest clinical literature, and automates prior authorizations and clinical workflows.

The business model is enterprise SaaS subscriptions across all B2B segments, with quote-based pricing initiated through "Request a demo" CTAs on every product page; pricing, contract values, and discount structures are not publicly disclosed. Go-to-market is dual-motion: enterprise field sales targeting clinics, payers, employers, and life sciences companies, paired with a self-serve direct-to-consumer patient platform that functions both as a standalone consumer tool and as a top-of-funnel funnel for provider and payer solutions. The company supplements direct sales with content-led demand generation through a suite of free public tools — The Fertility Atlas (an interactive knowledge graph), the IVF World Map, US and Europe Clinic Directories, a Clinical Trials Search, and a Fertility Innovations tracker — alongside a LinkedIn presence and email newsletter.

Louise is privately held with no disclosed funding history, no disclosed headcount, no named leadership, and no disclosed investor base; its operating geographies span France and the United States, and it maintains GDPR and CCPA-compliant privacy infrastructure. The company positions itself around quantified market gaps — approximately 1 in 5 people needing access to medically assisted reproduction, 98% of whom never receive care, and a 70% current treatment failure rate — as the problem space its AI infrastructure is designed to address.

Name

Louise

Legal name

Sofia SAS

Website

https://louise.life

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

Louise (Sofia SAS) is a France-based company building an AI-powered reproductive intelligence platform that serves patients, fertility clinics, health systems, payers, employers, and life sciences companies with clinical reasoning, predictive analytics, and workflow automation across the reproductive health journey.

Ownership category

akta.pro rank

Product category

Reproductive Health Technology

NAICS

Custom Computer Programming Services (541511)

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

Fertility & Reproductive Endocrinology Telehealth (IVF/IUI, infertility evaluation) (HLALAHAA)

akta.pro secondary industries

Care Navigation, Referral & Digital Front Door Platforms (HLALABAH), Women’s Health & Fertility Therapeutics (Digital) (HLACANAK), Patient Engagement, Education & Messaging Platforms (portal/CRM integrated) (HLALABAJ)

Keywords

• Reproductive intelligence platform
• Fertility clinical decision support
• AI healthcare analytics
• Fertility benefit management
• Reproductive health software

Headquarters

HQ city

Bordeaux

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Clinic Intelligence Platform: Revenue from fertility clinics via subscription for operational intelligence, patient acquisition, revenue cycle visibility, and clinical decision support. Clinics pay for end-to-end AI-powered solutions that improve outcomes while growing sustainably.
2. Payer Analytics Platform: Revenue from insurance companies and payers for fertility benefit analytics, claims pattern analysis, provider performance scoring, and outcomes-based contracting tools. Enables payers to optimize fertility benefit spend and member outcomes.
3. Employer Fertility Benefits: Revenue from employers offering fertility benefits to employees. Louise provides personalized fertility benefit guides, provider matching, utilization reporting, and outcomes tracking as an employer benefit solution.
4. Life Sciences Research Tools: Revenue from life sciences companies for real-world evidence generation, patient recruitment tools, market intelligence, and regulatory-grade datasets for reproductive health research and drug development.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

Louise builds an AI-powered reproductive intelligence platform that delivers end-to-end clinical reasoning, predictive analytics, and workflow automation across the reproductive health journey. The platform serves multiple stakeholder segments through dedicated solutions: a patient-facing portal for personalized fertility guidance, a clinic management platform for fertility clinics, a payer analytics platform for insurers, an employer fertility benefits platform, and a life sciences research platform for real-world evidence and patient recruitment.

Product overview

Louise offers a unified AI-powered reproductive intelligence platform with multiple integrated modules serving patients, fertility clinics, payers/health insurers, health systems, life sciences companies, and employers. The platform is architected around core AI infrastructure that provides clinical reasoning support, predictive analytics, and workflow automation across the reproductive health journey. Supporting the platform are specialized tools including The Fertility Atlas (interactive knowledge graph), IVF World Map (historical visualization), US and Europe Clinic Directories, Clinical Trials Search, and Fertility Innovations tracker. The platform serves as the central intelligence layer connecting fragmented care across disconnected specialists.

Differentiator

Problem solved

Functional benefit

Products and services

• Louise Reproductive Intelligence Platform The main AI-powered reproductive intelligence platform providing end-to-end clinical reasoning support and health insights for patients, providers, payers, health systems, life sciences companies, and employers across the reproductive health journey.
• Patient Portal Personalized guidance through every reproductive health journey including one connected journey from first question to outcome, personalised protocols shaped by unique biology, predictive insights, always-on guidance, and full cost transparency for individual patients.
• Clinic Management Platform End-to-end clinical reasoning support and reproductive health insights for fertility clinics, including operational intelligence, patient acquisition, and revenue cycle visibility.
• Payer Analytics Platform Precision benefit architecture and outcomes-driven care navigation for insurance payers, providing real-time fertility benefit analytics, claims pattern analysis, and outcomes-based provider contracts.
• Life Sciences Platform Real-world evidence generation and accelerated patient recruitment for life science companies, including regulatory-grade evidence packages, prescriber behaviour analytics, and market access strategy tools.
• Employer Fertility Benefits Platform Fertility benefits management for employers including personalised benefit guides, guided provider matching, utilisation and outcomes reporting, and retention impact analysis.
• The Fertility Atlas Interactive knowledge graph of human fertility biology tracing connections between conditions, genes, treatments, and mechanisms, with every link sourced from peer-reviewed research.
• US Clinic Directory Searchable directory of every ART clinic in the United States, filterable by state, city, and program type, built from SART and CDC reporting data.
• Europe Clinic Directory Fertility clinic directory across Europe mapped country by country, starting with France's ABM-authorized ART centres, with ability to compare success rates and explore coverage.
• Clinical Trials Search Search tool for active fertility clinical trials across ClinicalTrials.gov, browsable by condition including PCOS, endometriosis, RPL, and IVM, with recruitment status tracking.

Quantifiable outcome

• 70% of current fertility treatments fail, indicating significant room for improvement through AI-powered reproductive intelligence
• +1 more outcomes

Segments6 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature9 records

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Ro: Direct-to-consumer digital health platform with a fertility vertical (Ro Fertility). Comparable for the D2C patient acquisition motion and digital care delivery model.
• Prelude Fertility: Network of fertility clinics offering comprehensive reproductive services including IVF, egg freezing, and genetics. Overlaps with Louise on the clinic intelligence and patient-facing segments.
• Progyny: Public, well-capitalized fertility benefits management incumbent serving large employers and payers. A broad incumbent in Louise's payer and employer segments with deeper enterprise traction.

Direct peers

• Kindbody: Operates fertility clinics directly while offering employer-sponsored fertility benefits and virtual care. Competes with Louise on both the clinic-side intelligence and employer/payer benefits offerings.
• Maven Clinic: Virtual care platform for women's and family health spanning fertility, pregnancy, and pediatrics. Direct competitor to Louise's patient-facing virtual care and employer benefits offerings with similar multi-stakeholder model.
• Carrot Fertility: Leading fertility benefits platform for employers and payers, offering provider matching, education, and outcome tracking. Competes directly with Louise's employer fertility benefits product.

Emerging players

• Genea Biomedx: Fertility technology provider developing AI-enabled ART lab equipment and clinical workflow tools. Comparable as a fertility-tech specialist serving clinics with AI-enhanced solutions.
• Alife Health: AI-focused fertility company developing clinical decision support for IVF clinics including embryo selection and stimulation optimization. Directly comparable as an emerging AI player targeting the same clinic segment.
• Genomic Prediction: Provider of preimplantation genetic testing (PGT) and embryo-level predictive analytics. Overlaps with Louise's embryo-level outcome prediction and life sciences research tools.
• Overture Life: Fertility technology company applying automation and AI to IVF lab workflows including embryo handling and selection. Comparable as a fertility-tech emerging player serving clinics with innovative technology.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/louiselife

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Louise